TY - JOUR
T1 - Differential regulation of the mesoaccumbens circuit by serotonin 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors
AU - McMahon, Lance R.
AU - Filip, Malgorzata
AU - Cunningham, Kathryn A.
PY - 2001/10/1
Y1 - 2001/10/1
N2 - Serotonin [5-hydroxytryptamine (5-HT)] 5-HT2A and 5-HT2C receptors (5-HT2ARs and 5-HT2CRs), which innervate the dopamine mesoaccumbens pathway, may play an important role in the behavioral effects of cocaine. To test this hypothesis, the present study measured cocaine-evoked locomotor activity after bilateral microinjection of selective 5-HT2AR and 5-HT2CR antagonists into the ventral tegmental area (VTA) or the nucleus accumbens (NAc) shell. Locomotor activity was measured after intracranial microinjection of saline (0.2 μl/ side), the selective 5-HT2AR antagonist R-(+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenylethyl)]-4-piperidine methanol (M100907) (0.1 or 0.3/μg · 0.2 μl-1 · side-1), or the selective 5-HT2CR antagonist 8-[5-(2,4-dimethoxy-5-(4-trifluoromethylphenylsulfon-amido) phenyl-5-oxopentyl)]-1,3,8-triazaspiro[4.5]decane-2,4-dione hydrochloride (RS 102221) (0.05-0.5 μg · 0.2 μl-1 · side-1) followed by an injection of saline (1 ml/kg, i.p.) or cocaine (10 mg/kg, i.p.). Microinjection of M100907 (0.1-0.3 μg/side) into the VTA or RS 102221 (0.15-0.5 μg/side) into the NAc shell attenuated cocaine-induced hyperactivity in a dose-related manner. However, hyperactivity evoked by cocaine was not altered by microinjection of RS 102221 into the VTA or M100907 into the NAc shell. No changes in basal activity were observed after microinjection of M100907 or RS 102221 into either brain region. These findings are the first to demonstrate that the behavioral effects of cocaine are generated in part by activation of 5-HT2ARs in the VTA and by activation of 5-HT2CRs in the NAc shell. The selective regulation of the mesoaccumbens circuit by 5-HT2ARs and 5-HT2CRs implicates these 5-HT receptors as important in the behavioral outcomes of systemic cocaine administration.
AB - Serotonin [5-hydroxytryptamine (5-HT)] 5-HT2A and 5-HT2C receptors (5-HT2ARs and 5-HT2CRs), which innervate the dopamine mesoaccumbens pathway, may play an important role in the behavioral effects of cocaine. To test this hypothesis, the present study measured cocaine-evoked locomotor activity after bilateral microinjection of selective 5-HT2AR and 5-HT2CR antagonists into the ventral tegmental area (VTA) or the nucleus accumbens (NAc) shell. Locomotor activity was measured after intracranial microinjection of saline (0.2 μl/ side), the selective 5-HT2AR antagonist R-(+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenylethyl)]-4-piperidine methanol (M100907) (0.1 or 0.3/μg · 0.2 μl-1 · side-1), or the selective 5-HT2CR antagonist 8-[5-(2,4-dimethoxy-5-(4-trifluoromethylphenylsulfon-amido) phenyl-5-oxopentyl)]-1,3,8-triazaspiro[4.5]decane-2,4-dione hydrochloride (RS 102221) (0.05-0.5 μg · 0.2 μl-1 · side-1) followed by an injection of saline (1 ml/kg, i.p.) or cocaine (10 mg/kg, i.p.). Microinjection of M100907 (0.1-0.3 μg/side) into the VTA or RS 102221 (0.15-0.5 μg/side) into the NAc shell attenuated cocaine-induced hyperactivity in a dose-related manner. However, hyperactivity evoked by cocaine was not altered by microinjection of RS 102221 into the VTA or M100907 into the NAc shell. No changes in basal activity were observed after microinjection of M100907 or RS 102221 into either brain region. These findings are the first to demonstrate that the behavioral effects of cocaine are generated in part by activation of 5-HT2ARs in the VTA and by activation of 5-HT2CRs in the NAc shell. The selective regulation of the mesoaccumbens circuit by 5-HT2ARs and 5-HT2CRs implicates these 5-HT receptors as important in the behavioral outcomes of systemic cocaine administration.
KW - 5-HT receptor
KW - 5-HT receptor
KW - Behavior
KW - Cocaine
KW - Nucleus accumbens
KW - Serotonin
KW - Ventral tegmental area
UR - http://www.scopus.com/inward/record.url?scp=0035478667&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035478667&partnerID=8YFLogxK
U2 - 10.1523/jneurosci.21-19-07781.2001
DO - 10.1523/jneurosci.21-19-07781.2001
M3 - Article
C2 - 11567068
AN - SCOPUS:0035478667
SN - 0270-6474
VL - 21
SP - 7781
EP - 7787
JO - Journal of Neuroscience
JF - Journal of Neuroscience
IS - 19
ER -